
Immunotherapy drug nearly eliminates severe acute graft-versus-host disease
Results from a phase 2 clinical trial, presented by Seattle Children's Research Institute at the 59th American Society of Hematology (ASH) Annual Meeting, show that the drug Abatacept (Orencia) nearly eliminated life-threatening ...
Dec 9, 2017
0
171